Vacci-nation: A case study in health and prosperity
Article
Vaccines have been integral to health and prosperity in the last three centuries.
The Covid-19 vaccination has again demonstrated the value of vaccines – to lives, livelihoods, and national prosperity. Despite that success, it is imperative that the UK isn’t complacent: there is still huge room for improvement.
Doing better on vaccines could support population health, NHS system readiness and the economy. The key lesson from the Covid-19 vaccination programme is that an overly individualised approach to vaccine uptake and inequality is fundamentally limited.
On that basis, our policy recommendations explore how we can move ahead on vaccines, by harnessing the role of innovation, a wider range of public institutions, government, and businesses to support equality in access, uptake, and outcomes.
Related items
Realism and progress: How should the UK think about international policy in 2024?
Given the current polls, the Labour party looks set to form the next government. It has taken the temperature of the country and, whereas in 1997 its leaders put hope at the heart of their campaign, this time they have chosen to focus on…Rock bottom: Low investment in the UK economy
The UK’s investment performance is still worse than every other G7 country, new data shows.There is an alternative to traditional ways of delivering social and economic value
Our new report An alternative is possible: Measuring the impact of cooperatives puts forward a new framework for measuring the value that cooperative organisations deliver to local economies.